Drug:
Reaction: NO ADVERSE EVENT
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555338 |
US |
17 | 1 |
Product dose omission issue, Device defective, No adverse event, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 2 | 26555353 |
|||
No adverse event, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PREDNISONE, |
||||
| 3 | 26555503 |
US |
1 | |
Drug ineffective, Wrong product administered, No adverse event, |
||||
FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE, |
||||
| 4 | 26555504 |
US |
2 | |
Drug ineffective, No adverse event, |
||||
FEXOFENADINE HYDROCHLORIDE, |
||||
| 5 | 26555572 |
18 | ||
No adverse event, |
||||
BIMEKIZUMAB, |
||||
| 6 | 26555997 |
US |
47 | 2 |
Overdose, No adverse event, |
||||
DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 7 | 26556053 |
US |
27 | 2 |
Device defective, Product dose omission issue, No adverse event, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 8 | 26556231 |
US |
||
Expired product administered, No adverse event, |
||||
| 9 | 26556773 |
US |
||
No adverse event, Product prescribing error, |
||||
BUDESONIDE, |
||||
| 10 | 26557226 |
US |
||
Product storage error, No adverse event, |
||||
OCRELIZUMAB, |
||||
| 11 | 26557808 |
US |
||
Product storage error, No adverse event, |
||||
| 12 | 26557952 |
US |
51 | |
Product use issue, No adverse event, |
||||
TOLVAPTAN, TOLVAPTAN, |
||||
| 13 | 26557988 |
US |
||
Inappropriate schedule of product administration, No adverse event, |
||||
| 14 | 26558187 |
US |
2 | |
Drug ineffective, No adverse event, |
||||
TOCILIZUMAB, |
||||
| 15 | 26558318 |
US |
28 | 1 |
No adverse event, Device malfunction, Incorrect dose administered, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 16 | 26558327 |
US |
1 | |
Product storage error, Drug delivery system issue, No adverse event, |
||||
TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 17 | 26558423 |
US |
1 | |
Product dose omission issue, No adverse event, |
||||
SITAGLIPTIN, |
||||
| 18 | 26558460 |
US |
2 | |
Drug ineffective, No adverse event, |
||||
OMALIZUMAB, |
||||
| 19 | 26558735 |
US |
33 | |
No adverse event, |
||||
TIRZEPATIDE, |
||||
| 20 | 26558798 |
US |
2 | |
Product delivery mechanism issue, No adverse event, |
||||
TRIAMCINOLONE ACETONIDE, |
||||
| 21 | 26558841 |
US |
||
Device loosening, No adverse event, Device leakage, |
||||
RANIBIZUMAB, RANIBIZUMAB, |
||||
| 22 | 26558935 |
US |
22 | 2 |
Expired product administered, No adverse event, |
||||
| 23 | 26558941 |
US |
52 | 1 |
Expired product administered, No adverse event, |
||||
| 24 | 26558942 |
US |
37 | 2 |
Expired product administered, No adverse event, |
||||
| 25 | 26558943 |
US |
19 | 2 |
Expired product administered, No adverse event, |
||||
| 26 | 26559137 |
US |
2 | |
Death, No adverse event, |
||||
| 27 | 26559564 |
47 | ||
No adverse event, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 28 | 26559945 |
US |
1 | |
Product dose omission issue, Product use issue, No adverse event, |
||||
SITAGLIPTIN PHOSPHATE, |
||||
| 29 | 26560603 |
US |
||
Device connection issue, No adverse event, |
||||
LABETALOL HYDROCHLORIDE, LABETALOL, |
||||
| 30 | 26560687 |
US |
||
Product contamination, Inappropriate schedule of product administration, No adverse event, |
||||
BEVACIZUMAB, |
||||
| 31 | 26560920 |
JP |
8 | 1 |
Device delivery system issue, Device failure, Device safety feature issue, No adverse event, |
||||
ABATACEPT, |
||||
| 32 | 26560969 |
US |
12 | 2 |
Product storage error, No adverse event, |
||||
| 33 | 26560996 |
US |
||
Product storage error, No adverse event, |
||||
| 34 | 26561389 |
US |
4 | 1 |
Product prescribing issue, No adverse event, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, |
||||
| 35 | 26561608 |
US |
10 | |
Inappropriate schedule of product administration, No adverse event, |
||||
| 36 | 26550099 |
US |
2 | |
Product dose omission issue, Product complaint, No adverse event, |
||||
OMALIZUMAB, |
||||
| 37 | 26550110 |
US |
||
Intercepted product storage error, No adverse event, |
||||
OMALIZUMAB, |
||||
| 38 | 26550155 |
US |
1 | |
Drug ineffective, No adverse event, |
||||
OMALIZUMAB, |
||||
| 39 | 26550329 |
US |
1 | |
Device issue, No adverse event, Product dose omission issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, |
||||
| 40 | 26551158 |
US |
||
Expired product administered, No adverse event, |
||||
FEXOFENADINE HYDROCHLORIDE, |
||||
| 41 | 26551165 |
US |
69 | 1 |
Wrong technique in product usage process, No adverse event, |
||||
FEXOFENADINE HYDROCHLORIDE, |
||||
| 42 | 26551166 |
US |
||
Drug effective for unapproved indication, No adverse event, |
||||
LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 43 | 26551177 |
US |
2 | |
Wrong dose, No adverse event, |
||||
FEXOFENADINE HYDROCHLORIDE, |
||||
| 44 | 26551262 |
US |
||
Expired product administered, No adverse event, |
||||
| 45 | 26551364 |
US |
||
No adverse event, |
||||
TIRZEPATIDE, |
||||
| 46 | 26551456 |
US |
3 | |
Wrong product administered, No adverse event, Accidental overdose, |
||||
| 47 | 26551502 |
US |
2 | |
No adverse event, Product dose omission issue, |
||||
VEDOLIZUMAB, |
||||
| 48 | 26551527 |
US |
||
Expired product administered, No adverse event, |
||||
| 49 | 26551579 |
US |
1 | |
Off label use, No adverse event, |
||||
TRASTUZUMAB, PANITUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ROMIPLOSTIM, |
||||
| 50 | 26551582 |
US |
82 | 2 |
Product dose omission issue, No adverse event, Product storage error, Product container issue, |
||||
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION, DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, |
||||
| 51 | 26551583 |
US |
75 | 2 |
Product dose omission issue, Inadequate aseptic technique in use of product, No adverse event, Product container issue, |
||||
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION, DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, LATANOPROST, |
||||
| 52 | 26551584 |
US |
35 | 1 |
No adverse event, Product temperature excursion issue, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 53 | 26551595 |
US |
1 | |
No adverse event, Device malfunction, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 54 | 26551598 |
US |
60 | 1 |
No adverse event, Product use issue, |
||||
DEXLANSOPRAZOLE, |
||||
| 55 | 26552057 |
US |
2 | |
Product storage error, No adverse event, |
||||
TOCILIZUMAB, |
||||
| 56 | 26552179 |
US |
2 | |
Accidental exposure to product, Device defective, No adverse event, |
||||
TOCILIZUMAB, TOCILIZUMAB, |
||||
| 57 | 26552192 |
US |
0 | |
Product storage error, No adverse event, |
||||
| 58 | 26552203 |
US |
2 | |
Product delivery mechanism issue, No adverse event, |
||||
TRIAMCINOLONE ACETONIDE, |
||||
| 59 | 26552204 |
US |
2 | |
Product delivery mechanism issue, No adverse event, |
||||
TRIAMCINOLONE ACETONIDE, |
||||
| 60 | 26552266 |
US |
1 | 2 |
Product storage error, No adverse event, |
||||
| 61 | 26552524 |
EU |
14 | 2 |
Suicide attempt, No adverse event, Intentional overdose, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 62 | 26552538 |
US |
17 | 2 |
No adverse event, Device defective, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 63 | 26552622 |
US |
2 | |
No adverse event, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 64 | 26552787 |
US |
||
No adverse event, |
||||
BIMATOPROST, |
||||
| 65 | 26553135 |
US |
2 | |
Product delivery mechanism issue, No adverse event, |
||||
TRIAMCINOLONE ACETONIDE, |
||||
| 66 | 26553142 |
US |
2 | |
Product delivery mechanism issue, No adverse event, |
||||
TRIAMCINOLONE ACETONIDE, |
||||
| 67 | 26553144 |
US |
2 | |
Product delivery mechanism issue, Product label issue, No adverse event, |
||||
TRIAMCINOLONE ACETONIDE, |
||||
| 68 | 26553396 |
US |
22 | 1 |
No adverse event, Product dose omission in error, |
||||
PRUCALOPRIDE, |
||||
| 69 | 26553578 |
US |
||
Product storage error, No adverse event, |
||||
ENTRECTINIB, |
||||
| 70 | 26553690 |
US |
88 | 2 |
Off label use, Off label use, No adverse event, |
||||
BEVACIZUMAB, |
||||
| 71 | 26553936 |
US |
63 | |
Product dose omission issue, No adverse event, |
||||
TOLVAPTAN, TOLVAPTAN, |
||||
| 72 | 26554289 |
EU |
14 | 2 |
Suicide attempt, Intentional overdose, No adverse event, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 73 | 26554363 |
US |
||
Expired product administered, No adverse event, |
||||
| 74 | 26554443 |
US |
17 | 2 |
Exposure during pregnancy, No adverse event, |
||||
| 75 | 26554469 |
US |
1 | 2 |
Product storage error, No adverse event, Wrong product administered, |
||||
| 76 | 26554642 |
|||
No adverse event, |
||||
NALTREXONE, |
||||
| 77 | 26554940 |
US |
43 | 2 |
Wrong product administered, No adverse event, Product administered to patient of inappropriate age, |
||||
| 78 | 26555038 |
2 | ||
Off label use, No adverse event, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 79 | 26555094 |
|||
No adverse event, |
||||
BIMEKIZUMAB, |
||||
| 80 | 26555105 |
US |
||
Expired product administered, No adverse event, |
||||
| 81 | 26548891 |
US |
||
Device malfunction, No adverse event, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 82 | 26549784 |
US |
||
Product storage error, No adverse event, |
||||
| 83 | 26549792 |
47 | ||
No adverse event, |
||||
BIMEKIZUMAB, |
||||
| 84 | 26549871 |
US |
||
Off label use, No adverse event, |
||||
TOCILIZUMAB, |
||||
| 85 | 26549879 |
47 | ||
No adverse event, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 86 | 26549880 |
TR |
||
No adverse event, |
||||
DEXAMETHASONE, BIMATOPROST, |
||||
| 87 | 26549882 |
US |
||
Device malfunction, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 88 | 26549883 |
US |
2 | |
Device malfunction, No adverse event, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 89 | 26549896 |
US |
||
No adverse event, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 90 | 26549918 |
US |
||
No adverse event, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 91 | 26566061 |
36 | 1 | |
No adverse event, |
||||
ARIPIPRAZOLE, |
||||
| 92 | 26546763 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 93 | 26546764 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 94 | 26546765 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 95 | 26546766 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 96 | 26546768 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 97 | 26546770 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 98 | 26546771 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 99 | 26546772 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 100 | 26546774 |
US |
||
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28